The 'kynurenate test,' a biochemical assay for putative cognition enhancers

Journal of Pharmacology and Experimental Therapeutics

Volumn 283, Issue 1, 1997, Pages 82-90

  Pittaluga, Anna ^a   Vaccari, Daniella ^a   Raiteri, Maurizio ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b Ist Farmacologia e Tossicologia   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINOPROPYLBUTYLPHOSPHINIC ACID; [3 (3,4 DICHLOROBENZYLAMINO)PROPYL](DIETHOXYMETHYL)PHOSPHINIC ACID; ANIRACETAM; KYNURENIC ACID; LINOPIRDINE; N METHYL DEXTRO ASPARTIC ACID; NICOTINE; OXIRACETAM; TACRINE;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN SLICE; COGNITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG POTENTIATION; DRUG RECEPTOR BINDING; ENHANCER REGION; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPTOSOME;

ANIMALS; COGNITION; KYNURENIC ACID; MALE; NOREPINEPHRINE; ORGANOPHOSPHORUS COMPOUNDS; PENTANOIC ACIDS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; SERINE;

EID: 0030881811     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. ARNERIC, S. P., SULLIVAN, J. P. AND WILLIAMS, M.: Neuronal nicotinic acetylcholine receptors. Novel targets for central nervous system therapeutics. In Psychopharmacology: The Fourth Generation of Progress, ed. by F. E. Bloom and D J Kupfer, pp. 95-110, Raven Press, New York, 1995.
2. BARTUS, R. T., DEAN III, R. L., BEER, B. AND LIPPA, S.: The cholinergic hypothesis of geriatric memory dysfunction. Science 217: 408-417, 1985.
3. B receptor antagonists: potential thera-peutic applications. In GABA: Receptors, Transporters and Metabolism, ed. by C. Tanaka and N. G. Bowery, pp. 297-305, Birkhäuser Verlag, Basel/ Switzerland, 1996.
4. BLISS, T. V. P. AND COLLINGRIDGE, G. L.: A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361: 31-39, 1993.
5. B receptors. Trends Pharmacol. Sci. 14: 259-261, 1993.
6. B antagonist CGP36742 enhances spatial learning performance and antagonises baclofen-induced amnesia in mice. Br. J. Pharmacol. 109: suppl., 74P, 1993.
7. CASTELLANO, C., BRIONI, J. D. AND MCGAUGH, J. L.: GABAergic modulation of memory. In The Biology of Memory, ed. by L. R. Squire and E. Lindenlaub, pp. 361-378, Symposia Medica Hoechst 23, Schattauer, Stuttgart/New York, 1990.
8. CHAN PALAY, V.: Alterations in the locus coeruleus in dementias of Alzheimer's and Parkinson's disease. Prog. Brain Res. 88: 625-630, 1991.
9. 3H]dopamine release. Br. J. Pharmacol. 117: 595-606, 1996.
10. DAVIS, K. L., THAL, L. J., GAMZU, E. R., DAVIS, C. S., WOOLSON, R. F., GRACON, S. I., DRACHMAN, D. A., SCHNEIDER, L. S., WHITEHOUSE, P. J., HOWEVER, T. M., MORRIS, J. C., KAWAS, C. H., KNOPMAN, D. S., EARL, N. L., KUMAR, V., DOODY, R. S. AND THE TACRINE COLLABORATIVE STUDY GROUP: A double-blind placebo-controlled multicenter study of tacrine for Alzheimer's disease. N. Engl. J Med. 327: 1253-1259, 1992.
11. FARLOW, M., GRACON, S. I., HERSHEY, L. A., LEWIS, K. W., SADOWSKY, C. H. AND DOLAN-UREN, J.: A controlled trial of tacrine in Alzheimer's disease. JAMA 268: 2523-2529, 1992.
12. FINK, K., SCHULTHEISS, R. AND GÖTHERT, M.: Stimulation of noradrenaline release in human cerebral cortex mediated by N-methyl-D-aspartate (NMDA) and non-NMDA receptors. Br. J. Pharmacol. 106: 67-72, 1992.
13. FONTANA, D. J., INOUYE, G. T. AND JOHNSON, R. M.: Linopirdine (DuP 996) improves performance in several tests of learning and memory by modulation of cholinergic neurotransmission. Pharmacol. Biochem. Behav. 49: 1075-1082, 1994.
14. B, antagonists. J. Med. Chem. 38: 3313-3331, 1995.
15. GAROFALO, P., COLOMBO, S., LANZA, M., REVEL, L. AND MAKOVEC, F.: CR2249: a new putative memory enhancer. Behavioural studies on learning and memory. J. Pharm. Pharmacol. 48: 1290-1297, 1996.
16. GERMAN, D. C., MANAYE, K. F., WHITE, C. L., WOODWARD, D. J., MCINTIRE, D. D., SMITH, W. K., KALARIA, R. N. AND MANN, D. M.: Disease-specific patterns of locus coeruleus cell loss. Ann. Neurol. 32: 667-678, 1992.
17. 3H]norepinephrine release from rat cortical slices. J. Pharmacol. Exp. Ther. 253: 1138-1144, 1990.
18. GRAMSBERGEN, J. B., SCHMIDT, W., TURSKI, W. A. AND SCHWAHCZ R.: Age-related changes in kynurenic acid production in rat brain. Brain Res. 588: 1-5, 1992.
19. 3H]MK801 binding. Eur. J. Pharmacol. 281: R11-R13, 1995.
20. HARLEY, C.: Noradrenergic and locus coeruleus modulation of the perforant path-evoked potential in rat dentate gyrus supports a role for the locus coeruleus in attentional and memorial processes. Prog. Brain Res. 88: 307-321. 1991.
21. HASHIMOTO, A., KUMASHIRO, S., NISHIKAWA, T., OKA, T., TAKAHASHI, K., MITO, T., TAKASHIMA, S., DOI, N., MIZUTANI, Y., YAMAZAKI, T., KANEKO, T. AND OOTOMO, E.: Embryonic development and postnatal changes in free D-aspartate and D-serine in the human prefrontal cortex. J. Neurochem. 61: 348-351, 1993.
22. HASHIMOTO, A., NISHIKAWA, T., HAYASHI, T., FUJII, N., HARADA, K., OKA, T. AND TAKAHASHI, K: The presence of free D-serine in rat brain. FEBS Lett. 296: 33-36. 1992.
23. HEYES, M. P., BREW, B. J., PRICE, R. W. AND MARKEY, S. P.: Cerebrospinal fluid quinolinic acid and kynurenic acid in HIV-I infection. In Neurotoxicity of Excitatory Amino Acid, ed. by A. Guidotti, pp. 217-226, Raven Press, New York, 1990.
24. HOOD, W. F., COMPTON, R. P. AND MONAHAN, J. B.: D-Cycloserine: a ligand for the N-methyl-D-aspartate coupled glycine receptor has partial agonist characteristic. Neurosci. Lett. 98: 91-95, 1989.
25. HUANG, Y.-Y. AND KANDEL, E. R.: Modulation of both the early and the late phase of mossy fiber LTP by the activation of β-adrenergic receptors. Neuron 16: 611-617, 1996.
26. ISAACSON, J. S. AND NICOLL, R. A.: Aniracetam reduces glutamate receptor desensitization and slows the decay of fast excitatory synaptic currents in the hippocampus. Proc. Natl. Acad. Sci. U.S.A. 88: 10936-10940, 1991.
27. ITO, J., TANABE, S., KOHDA, A. AND SUGIYAMA, H.: Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam. J. Phvsiol. 424: 533-543, 1990.
28. IZQUIERDO, I., MEDINA, J. H., BIANCHIN, M., WALZ, R., ZANATTA, M. S., DA SILVA, R. C., SILVA, M. B. E., RUSCHEL, A. C. AND PACZKO N.: Memory processing by the limbic system: role of specific neurotransmitter systems. Behav. Brain Res. 58: 91-98, 1993.
29. JOHNSON, J. W. AND ASCHER, P.: Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 325: 529-531, 1987.
30. JONES, R. W., WESNES, K. A. AND KIRBY, J.: Effects of NMDA modulation in scopolamine dementia. Ann. NY Acad. Sci. 640: 241-244, 1991.
31. JONES, S. M., SNELL, L. D. AND JOHNSON, K. M.: Phencyclidine selectively inhibits N-methyl-D-aspartate-induced hippocampal [3H]norepinephrine release. J. Pharmacol. Exp. Ther. 240: 492-497, 1987.
32. KEMP, J. A. AND LEESON, P. D.: The glycine site of the NMDA receptor: five years on. Trends Pharmacol. Sci. 14: 20-25, 1993.
33. KESSLER, M., TERRAMANI, T., LYNCH, G. AND BAUDRY, M.: A glycine site associated with N-methyl-D-aspartic acid receptors: characteristics and identification of a new class of antagonists. J. Neurochem. 52: 1319-1328, 1989.
34. KLECKNER, N. W. AND DINGLEDINE, R.: Requirement for glycine in activation of N-methyl-D-aspartate receptors expressed in Xenopus oocytes. Science 241: 835-837, 1988.
35. LANZA, M., BONNAFOUS, C., COLOMBO, S., REVEL, L. AND MAKOVEC, F.: Characterization of a novel putative cognition enhancer mediating facilitation of glycine effect on strychnine-resistant sites coupled to NMDA receptor complex. Neuropharmacology 36:1057-1064, 1997.
36. 3H]acetylcholine from rat striatal slices. Brain Res. 252: 77-89, 1982.
37. LEHMANN, J., VALENTINO, R. AND ROBINE, V.: Cortical norepinephrine release elicited in situ by NMDA receptor stimulation: a microdialysis study. Brain Res. 599: 171-174, 1992.
38. MARCHI, M. AND RAITERI, M.: Nicotinic autoreceptors mediating enhancement of acetylcholine release become operative in conditions of "impaired" cholinergic presynaptic function. J. Neurochem. 67: 1974-1981, 1996.
39. MCGAUGH, J. L.: Involvement of hormonal and neuromodulatory systems in the regulation of memory storage. Annu. Rev. Neurosci. 12: 255-287, 1989.
40. MISERENDINO, M. J. D., SANANES, C. B., MELIA, K. R. AND DAVIS, M.: Blocking of acquisition but not expression of conditioned fear-potentiated startle by NMDA antagonists in the amygdala. Nature 345: 716-718, 1990.
41. MONAGHAN, D. T., OLVERMAN, H. J., NGUYEN, L., WATKINS, J. C. AND COTMAN, C. W.: Two classes of N-methyl-D-aspartate recognition sites: differential distribution and differential regulation by glycine. Proc. Natl. Acad. Sci. U.S.A. 85: 9836-9840, 1988.
42. 3H]glycine recognition site as a modulatory site of the N-methyl-D-aspartate receptor complex. J. Neurochem. 53: 370-375, 1989.
43. B blocker improves the cognitive performance of mice, rats, and rhesus monkeys. Behav. Neural Biol. 60: 62-68, 1993.
44. MORONI, F., RUSSI, P., LOMBARDI, G., BENI, M. AND CARLÀ, V.: Presence of kynurenic acid in the mammalian brain. J. Neurochem. 51: 177-180, 1988a.
45. MORONI, F. RUSSI, P. CARLÀ, V. AND LOMBARDI, G.: Kynurenic acid is present in the rat brain and its content increases during development and aging process. Neurosci. Lett. 94: 145-150, 1988b.
46. MORRIS, R. G. M., ANDERSON, E., LYNCH, G. S. AND BAUDRY, M.: Selective impairment of learning blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist. Nature 319: 774-776, 1986.
47. NICKOLSON, V. J., TAM, S. V., MEYERS, M. J. AND COOK, L.: DuP996 (3,3(4-pyrindylmethyl)1-phenylindolin-2-one) enhances the stimulus evoked release of acetylcholine from rat brain in vitro and in vivo. Drug Dev. Res. 19: 285-300, 1990.
48. B receptor antagonists on GABAergic transmission in vivo and in vitro. Eur. J. Pharmacol. 233: 179-186, 1993.
49. PEPEU, G. AND SPIGNOLI, G.: Nootropic drugs and brain cholinergic mechanisms. Prog. Neuropsychopharmacol. Biol. Psychiatry 13: suppl., S77-S88, 1989.
50. PITTALUGA, A. AND RAITERI, M.: Release-enhancing glycine-dependent presynaptic NMDA receptors exist on noradrenergic terminals of hippocampus. Eur. J. Pharmacol. 191: 231-234, 1990.
51. PITTALUGA, A. AND RAITERI, M.: N-Methyl-d-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. I. Location on axon terminals and pharmacological characterization. J. Pharmacol. Exp. Ther. 260: 232-237, 1992.
52. PITTALUGA, A., PATTARINI, R. AND RAITERI, M.: Putative cognition enhancers reverse kynurenic acid antagonism at hippocampal NMDA receptors. Eur. J. Pharmacol. 272: 203-209. 1995.
53. RAITERI, M., ANGELINI, F. AND LEVI, G.: A simple apparatus for studying the release of neurotransmitters from synaptosomes. Eur. J. Pharmacol. 25: 411-414, 1974.
54. RAITERI, M., BONANNO, G., MARCHI, M. AND MAURA, G.: Is there a functional linkage between neurotransmitter uptake mechanisms and presynaptic receptors? J. Pharmacol. Exp. Ther. 231: 671-677, 1984.
55. 3H]norepinephrine release is modulated by glycine. Eur. J. Pharmacol. 156: 149-155, 1988.
56. SAHAKIAN, B. J., OWEN, A. M., MORANT, N. J., EAGGER, S. A., BODDINGTON, S., CRAYTON, L., CROCKFORD, H. A., CROOKS, M., HILL, K., LEVY, R.: Further analysis of the cognitive effects of tetrahydroaminuacridine (THA) in Alzheimer's disease: assessment of attentional and mnemonic function using CANTAB. Psychopharmacology 110: 395-401, 1993.
57. SARTER, M.: Taking stock of cognition enhancers. Trends Pharmacol. Sci. 12: 456-461, 1991.
58. SCHELL, M. J., MOLLIVER, M. E. AND SNYDER, S. H.: D-Serine, an endogenous synaptic modulator: localization to astrocytes and glutamate-stimulated release. Proc. Natl. Acad. Sci. U.S.A. 92: 3948-3952, 1995.
59. 3H-(1-1-(2-thienyl)cyclohexyl-piperidine) binding in rat hippocampus. Synapse 3: 129-135, 1989.
60. STONE, T. W.: Neuropharmacology of quinolinic and kynurenic acids. Pharmacol. Rev. 45: 309-379, 1993.
61. SWARTZWELDER, H. S., TILSON, H. A., MCLAMB, R. L. AND WILSON, W. A.: Baclofen disrupts passive avoidance retention in rats. Psychopharmacology 92: 398-401, 1987.
62. THOMAS P., STEPHENS, M., WILKIE, G., AMAR, M., LUNT, G. G., WHITING, P., GALLAGHER, T., PEREIRA, E., ALKONDON, M., ALBUQUERQUE, E. X. AND WONNACOTT, S.: (+)Anatoxin-a is a potent agonist at neuronal nicotinic acetykholine receptors. J. Neurochem. 60: 2308-2311, 1993.
63. TURSKI, W. A., NAKAMURA, M., TODD, W. P., CARPENTER, B. K., WETSELL, W. O. JR. AND SCHWARCZ, R.: Identification and quantification of kynurenic acid in human brain tissue. Brain Res. 454: 164-169, 1988.
64. 3H]Norepinephrine release from hippocampal slices in an in vitro biochemical tool for investigating the pharmacological properties of excitatory amino acid receptors. J. Neurochem. 49: 1438-1442, 1987.
65. ZACZEK, R. AND SAYDOFF, J. A.: Depolarization activated releasers of transmitters as therapeutics for dementia: Preclinical characterization of linopirdine (DuP996). Curr. Opin. Invest. Drugs 2: 1097-1104, 1993.
66. ZACZEK, R., TINKER, W. J. AND TAM, S. W.: Unique properties of norepinephrine release from terminals arising from the locus coeruleus: high potassium sensitivity and lack of linopirdine (DuP996) enhancement. Neurosci. Lett. 155: 107-111, 1993.